Updated 04:19 GMT, 16 Nov 2026 SPX 7,561.67 -0.40% NDX 27,943.74 -1.22% VIX 19.30 +3.21% GOLD 3,873.60 -0.33% CL 88.49 -0.08% BTC 64,896.46 +1.20%
NAS100 27,944 −1.22% S&P 7,562 −0.40% GOLD $3,874 −0.33% BTC $64,896 +1.20% VIX 19.30 +3.21% latest tape · as of 04:19 UTC
The Screen · Utilities · Utilities - Regulated Water

York Water Co

YORW · NASDAQ · USD · Market cap $510M · 129 employees

The York Water Company impounds, purifies, and distributes drinking water.

FAIL · Does not pass the screen
31.50 USD

Price as of 13 Nov 2026Daily close, not a live quote

Screened 2026-11-13 · the tape above runs as of 04:19 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed

Key facts today

  • Price31.50 USD at the 13 Nov 2026 close
  • Fair value25.83. Our model only; only one analyst covers it, too few to cross-check it.
  • Our value readOvervalued vs our fair value, as of 13 Nov 2026
  • Our regime readMarkup, as of 15 Nov 2026
  • Ethical screenDoes not pass
  • OptionsOpen interest leans heavily to calls (put/call 0.02)
  • Last reviewed13 Nov 2026 (3 days ago)
  • Release timesRelease and earnings times on your chart: Event Guard Mentor

A summary of the dated readings below, not a live quote and not advice.

PRICE · ONE YEAR

Our fair-value range: $25.83 to $29.71, base estimate $25.83 (screen dated 2026-11-13).

Current read
Markup ?
Overvalued · screened 2026-11-13
  • Trend Markup
  • Insiders insiders bought, latest filing 2026-09-21
  • Positioning no disclosures inside 60 days, left as found
  • Options put/call open interest 0.02, read 2026-11-15
  • Ethical does not pass the values gate
Price31.50 USD
Fair value25.83Our model only; only one analyst covers it, too few to cross-check it.
Ethical score70.0/100
Value readOvervaluedas of 13 Nov 2026
Our investment reviews on this name
2026-11-13Read Markup31.53-0.1% to today Accumulation gives way to Markup first Markup read since October
2026-11-01Read Accumulation31.59-0.3% to today Markup gives way to Accumulation first Accumulation read since July
2026-10-29Read Markup31.82-1.0% to today Markdown gives way to Markup first Markup read since August
2026-09-18Read Markdown31.45+0.2% to today Markup gives way to Markdown

Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.

The full research record, in depth, below
The Label · The Season, Not the Day

This name holds its markup label.

York Water Co holds its Markup at $31.50. Consolidating, no directional conviction, held for 580 days.

As held on the ledger · 2026-11-13
PhaseMarkup
Quantitative stateConsolidating, no directional conviction, held for 580 days
Price at the screen$31.50
Valuation21.90 trailing · 21.04 forward price to earnings
Values screenFAIL · score 70.0
Beta0.62
The Workings

Five Screens, Shown in Full

Does not pass. Debt ratio

TestFigureLimitWhat it meansStatus
Business activity Permissible Core business clean Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. Pass
Debt load 34.11% Below 33% Interest-bearing debt is 34.1% of its assets, above the one-third ceiling the screen allows. Fail
Interest-bearing cash 0.00% Below 33% Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit. Pass
Receivables 1.29% Below 49% Money owed to the company is 1.3% of assets, under the 49% limit. Pass

Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.

The Ethical Read

Why It Falls Short, in Plain English

York Water Co's business is in a permissible area, but its interest-bearing debt is about 34% of the company, just over the ~33% line, so it does not pass on the financial screens.

Read as at 2026-11-14. It updates when the underlying figures move, and past reads are kept below.

Follow this verdict

Get an email when YORW's ethical verdict changes

Today YORW does not pass the screen. If new figures move it to a pass, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.

Free, no account needed. Every email has a link to stop.

What the Numbers Say It Is Worth

The Fair Value Range

Our model only; only one analyst covers it, too few to cross-check it.

Our analysis reads Overvalued vs our fair value, as of 13 Nov 2026: it trades above our $25.83 fair value estimate, none competitive moat, 8.80% revenue growth.

How a fair value is estimated: discounted cash flow (DCF).

25.83Conservative25.83Base case29.71Growth case 31.50Price

Fair value range in USD, drawn from the 2026-11-13 screen. The gold marker is the market price at the same screen. The price runs 22.0% above the base estimate.

Reading the gap · Both our model and the Street see limited upside at this price.

Price History & Projections

Where our models see it going: fair-value estimate $25.83, with a range of $25.83 to $29.71, dated to the 2026-11-13 screen.

Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.

The Business, in Plain Words

Why it gives us pause

At 21.0x forward earnings, the price already runs ahead of the business. It trades 22% above our $25.83 fair value, so you would be buying at a premium, not a discount. The none moat is real, but quality alone does not make an expensive price cheap.

The fundamentals · plain-English read
Forward P/E21.0xexpensive even after accounting for its growth
Trailing P/E21.9xa premium valuation
EPS, trailing1.47
EPS, forward1.53
Revenue growth+8.8%steady growth
Profit margin26.8%healthy profit margins
Return on equity9.0%a modest return on shareholder capital
FCF yield-5.68%
Dividend yield3.09%
Debt to equity0.98moderate, manageable leverage
Current ratio0.72below 1: short-term bills exceed liquid assets
Beta0.62steadier than the market
Short interest, float0.04%
52-week range28.26 - 34.30
MoatNONE
Market cap$510M
Employees129

Another profit measure, before interest, tax and non-cash costs: EBITDA.

The risks · The things to watch: it's a small-cap, so the share price can swing harder than the market.

Plain-English interpretation of our own screen data. Analysis, not advice.

Where & How to Trade

YORW trades on NASDAQ. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.

The Dated Journal · Newest First, Never Edited

Every Entry, As Written

2026-11-13 Markup · changed $31.53 -2.1% Entry 18

The framework has shifted from accumulation to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 2.1% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 3% above its long-term trend line with momentum reading overbought. Over the past year the shares are down 5%. Our forward projection puts the odds of a 10% gain over the next month near 7%. The street (1 analysts) rates it none, with a mean price target of $30. Insiders have been net buyers over the past quarter.

2026-11-06 Accumulation $32.22 -0.1% Entry 17

The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.1% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 1% above its long-term trend line with momentum reading bullish. Over the past year the shares are down 5%. Our forward projection puts the odds of a 10% gain over the next month near 7%. The street (1 analysts) rates it none, with a mean price target of $30. Insiders have been net buyers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.

2026-11-05 Accumulation $32.26 +1.8% Entry 16

The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 1.8% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 1% above its long-term trend line with momentum reading bullish. Over the past year the shares are down 5%. Our forward projection puts the odds of a 10% gain over the next month near 7%. The street (1 analysts) rates it none, with a mean price target of $30. Insiders have been net buyers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.

2026-11-04 Accumulation $31.69 +0.3% Entry 15

The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 0.3% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 1% above its long-term trend line with momentum reading bullish. Over the past year the shares are down 5%. Our forward projection puts the odds of a 10% gain over the next month near 7%. The street (1 analysts) rates it none, with a mean price target of $30. Insiders have been net buyers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.

2026-11-03 Accumulation $31.59 +0.0% Entry 14

The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 1% above its long-term trend line with momentum reading bullish. Over the past year the shares are down 5%. Our forward projection puts the odds of a 10% gain over the next month near 7%. The street (1 analysts) rates it none, with a mean price target of $30. Insiders have been net buyers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.

2026-11-02 Accumulation $31.59 +0.0% Entry 13

The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 1% above its long-term trend line with momentum reading bullish. Over the past year the shares are down 5%. Our forward projection puts the odds of a 10% gain over the next month near 7%. The street (1 analysts) rates it none, with a mean price target of $30. Insiders have been net buyers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.

2026-11-01 Accumulation · changed $31.59 -0.7% Entry 12

The framework has shifted from markup to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.7% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 1% above its long-term trend line with momentum reading bullish. Over the past year the shares are down 5%. Our forward projection puts the odds of a 10% gain over the next month near 7%. The street (1 analysts) rates it none, with a mean price target of $30. Insiders have been net buyers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.

2026-10-31 Markup $31.82 +0.0% Entry 11

The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 1% above its long-term trend line with momentum reading bullish. Over the past year the shares are down 5%. Our forward projection puts the odds of a 10% gain over the next month near 7%. The street (1 analysts) rates it none, with a mean price target of $30. Insiders have been net buyers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.

2026-10-30 Markup $31.82 +0.0% Entry 10

The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 1% above its long-term trend line with momentum reading bullish. Over the past year the shares are down 5%. Our forward projection puts the odds of a 10% gain over the next month near 7%. The street (1 analysts) rates it none, with a mean price target of $30. Insiders have been net buyers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.

2026-10-29 Markup · changed $31.82 +2.4% Entry 9

The framework has shifted from markdown to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 2.4% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 1% above its long-term trend line with momentum reading bullish. Over the past year the shares are down 5%. Our forward projection puts the odds of a 10% gain over the next month near 7%. The street (1 analysts) rates it none, with a mean price target of $30. Insiders have been net buyers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.

Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.

Related Securities · Others in YORW's Space

Screened names in the same industry · explore each on its own page.

The Insider Ledger · Form 4 Filings, As Filed
Most recent filings · YORW
DateInsiderTitleTypeSharesValue
2026-09-21 Brossman Douglas S Dir P - Purchase 30 $1,000

Public filings, recorded as found. The full tape lives at Insider Intelligence.

What Holding Actually Paid · Price Plus Dividends
If $1,000 had been placed · historical, not a promise
PeriodPrice thenPrice returnDivs per share$1,000 becameTotal return
1 month $29.56 +2.4% · $1,024 +2.4%
2 months $32.28 -6.2% · $938 -6.2%
3 months $31.30 -3.3% · $967 -3.3%
6 months $32.84 -7.8% $0.46 $936 -6.4%
1 year $31.77 -4.7% $0.89 $981 -1.9%
2 years $34.31 -11.8% $1.75 $933 -6.7%
3 years $41.70 -27.4% $2.58 $788 -21.2%
5 years $47.01 -35.6% $4.14 $732 -26.8%

Historical returns from market close data. Past performance does not guarantee future results.

The Ledger's Promise

This entry now belongs to the ledger. Whatever YORW does next, these words stay.

York Water Co · YORW · Markup · $31.50
Recorded 2026-11-13 · before the outcome · scored mechanically

Membership

Thirteen thousand names carry this page. One desk keeps them honest.

Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.

Join the desk

Screening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.

Get our weekly market brief free.